International Advisory Council
Effective management of MUG’s development in the area of research requires periodical verification of actions and operational correction of the executed initiatives. Diversification of the university’s practices in this matter will allow for utilization of the new tools that facilitate development and extend the scope of research. It will also allow for establishment of new international partnerships.
For the purpose of the monitoring of the Programme, International Advisory Council consisting of renowned experts from foreign medical universities and universities which are MUG benchmark is engaged. The aim of the Council is to ensure a fair assessment of the University activities and provide best world practices which will help the transformation of MUG into research university.
The council’s proceedings will be related to processing reports that contain information about the accomplished and ongoing projects at the university. Organizing such meetings will allow for continual assessment and verification of the current scientific activity of MUG. It will also facilitate continual update of key dimensions of action. Knowledge generated thanks to such meetings will be subsequently implemented – mainly in the framework of Priority Research Areas.
Experts
| Chairlady of the Council Prof. Dame Anna Dominiczak Regius Professor of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland |
 |
Prof. Dame Anna Dominiczak (149 KB) |
| PRA 1/Oncology Prof. Andrea Gallamini Department for Research, Medical Innovation & Statistics A. Lacassagne Cancer Center, Nice, France |
 |
Prof. Andrea Gallamini (189 KB) |
| PRA 1/Oncology Prof. Christoph C. Zielinski Director of the Clinical Division of Oncology and Chairman of the Department of Medicine I and the Comprehensive Cancer Centre at the Medical University of Vienna, Vienna, Austria |
 |
Prof. Christoph C. Zielinski (148 KB) |
| PRA2/Cardiology and cardiovascular medicine Prof. Reinhold Kreutz Director of the Institute of Clinical Pharmacology and Toxicology, Charité – Universitätsmedizin Berlin, Berlin, Germany |
 |
Prof. R. Kreutz (146 KB) |
| PRA2/Cardiology and cardiovascular medicine Prof. Giuseppe Mancia Professor Emeritus at the University Milano-Bicocca [after 20 years as Chairman of the Division and Department of Internal Medicine at the same University at the San Gerardo Hospital in Monza and Director of the Interuniversity (Universities of Milano, Milano-Bicocca and Pavia) Center for Clinical Physiology and Hypertension], Department of Clinical Medicine, University of Milano-Bicocca, Milan, Italy |
 |
Prof. Giuseppe Mancia (202 KB) |
| PRA 3/Biochemistry, genetics and molecular biology Prof. David R. Goodlett University of Maryland School of Pharmacy, Baltimore, USA |
 |
Prof. David R. Goodlett (160 KB) |
| PRA 3/Biochemistry, genetics and molecular biology Prof. Sir Magdi H. Yacoub National Heart and Lung Institute, Imperial College London and Founder and Director of Research at the Harefield Heart Science Centre (Magdi Yacoub Institute), London, England |
 |
Prof. Sir Magdi Habib Yacoub (140 KB) |
Visiting Professors
from left: Prof. Michel Burnier, Prof. Godefridus Peters, Prof. Paul Gründeman